Kaiqi Liu

12PUBLICATIONS
18CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 21, 2026
Venetoclax plus pediatric regimen in adolescents and adults with Ph-negative acute lymphoblastic leukemia.

|Feb 13, 2026
Impact of Fusion Partners and Transplantation Benefit in Intensively Treated KMT2A-Rearranged Acute Myeloid Leukemia.

Heng Shen, Jiayuan Chen, Xiaoyuan Gong

|Oct 28, 2025
Venetoclax combined with homoharringtonine, cytarabine and aclacinomycin as induction therapy in newly diagnosed Chinese acute myeloid leukaemia patients: A multicentre phase II study.

Yaxian Tan, Xingli Zhao, Xiaohui Suo

|Jun 30, 2025
Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|Nov 10, 2024
Risk stratification in the clinical application of minimal residual disease assessment in acute myeloid leukemia.

Congxiao Zhang, Runxia Gu, Huijun Wang

Pageof 2

Frequent Collaborators

6 joint publications

Jianxiang Wang

6 joint publications

Yingchang Mi

5 joint publications

Xiaoyuan Gong

5 joint publications

Shaowei Qiu